Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Tilray Medical
Acquired Company
RayThera
Description
Biogen Inc. announced the completion of its acquisition of RayThera Inc., enhancing its immunology portfolio. The acquisition includes multiple assets aimed at treating immune-mediated conditions. The lead program has entered Phase 1 development in July 2026, highlighting Biogen's commitment to innovation in this area. This acquisition reflects Biogen's strategy to strengthen and diversify its research pipeline.
Fundz sees it the moment Tilray Medical makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired RayThera?
RayThera was acquired by Tilray Medical, based in Seattle. The deal was reported on August 6, 2026. Tilray Brands, Inc. is a leading global lifestyle and consumer packaged goods company with a focus on cannabis, beverage, wellness, and entertainment. Tilray Medical is publicly traded (TLRY) and operates in Other.
When did Tilray Medical acquire RayThera?
Tilray Medical's acquisition of RayThera was reported on August 6, 2026. Biogen Inc. announced the completion of its acquisition of RayThera Inc., enhancing its immunology portfolio. The acquisition includes multiple assets aimed at treating immune-mediated conditions. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does RayThera do?
RayThera, Inc. is a small molecule drug discovery company focused on building an immunology pipeline. The company is led by a team of highly skilled drug hunters with extensive experience in the biotech and pharma industries. It is privately held, operating in Biotechnology, and is based in San Diego.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.